رفقة عماد
- French startup Verley raised €32M to scale up the production of lab-grown whey protein and launch it in the US market by year-end.
- The company uses “precision fermentation” to produce beta-lactoglobulin, a protein identical to traditional dairy but made without the need for cows.
- This expansion aims to address the global shortage of traditional protein supplies, especially with most US supply contracts already booked through 2026.
French startup Verley has successfully raised €32M (approximately $37.6M) to scale up the production of lab-grown whey proteins and begin sales in the US market before the end of this year. Notably, the company is a graduate of the Sunbolah program, an initiative by the Ministry of Environment, Water, and Agriculture.
This funding follows the company’s approval from the US Food and Drug Administration (FDA), allowing it to commercially launch its products as an alternative to proteins derived from cow’s milk.
Funding Details and Partners
- Investors: The round was led by the Paris-based fund Alven, with participation from Bpifrance and other investment entities.
- Total Funding: The company’s total investments have reached over €50M since its founding four years ago.
- Goal: To build production lines and provide protein to food and beverage companies in the United States.
What Makes This Protein Unique?
The company relies on “precision fermentation” technology to produce a protein called beta-lactoglobulin. This is the core component of whey, responsible for its nutritional value and texture.
Key Features of the Product:
- High Concentration: Suitable for small sports drinks (Protein Shots) that require a protein that dissolves easily without settling.
- Sustainable Alternative: Produced without the need for dairy farming, reducing the consumption of natural resources.
- Manufacturing Quality: The protein is tasteless, heat-tolerant, and can be used in various food types without altering their flavor.
Addressing Market Shortages
Global markets, especially in the US, are facing a shortage of traditional whey supplies, with most supply contracts already booked through 2026. Through its technology, Verley aims to provide a stable, alternative source to meet the growing demand from manufacturers, particularly in the health and sports nutrition sectors.
